Metabolic complications of endogenous Cushing: patient selection for screening

Metabolic complications of endogenous Cushing: patient selection for screening

Bibliographic Details
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2013-03-01
Series:	Ожирение и метаболизм
Subjects:	endogenous hypercortisolism complications of hypercortisolism acth cortisol cushing's disease
Online Access:	https://www.omet-endojournals.ru/jour/article/view/5068

Similar Items

Cushing’s disease – cardiovascular and metabolic complications
by: Marta Izabela Mazur, et al.
Published: (2019-11-01)

A pitfall of bilateral inferior petrosal sinus sampling in cyclic Cushing’s syndrome
by: Adriana Albani, et al.
Published: (2019-10-01)

Characterization of Adrenal miRNA-Based Dysregulations in Cushing’s Syndrome
by: Sharmilee Vetrivel, et al.
Published: (2022-07-01)

Factors predicting the outcomes of removal of corticotropinom in Cushing's disease
by: Evgenia I. Marova, et al.
Published: (2016-12-01)

Update in Cushing disease: What the neurosurgeon has to KNOW, on behalf of the EANS skull base section
by: Sayoa Eulate-Beramendi, et al.
Published: (2022-01-01)

Endogenous hypercortisolism in the patient with obesity: the cause or a competing disorder
by: Zhanna E. Belaya, et al.
Published: (2016-03-01)

Cortisol and Phosphate Homeostasis: Cushing’s Syndrome Is Associated With Reversible Hypophosphatemia
by: Ariadne Bosman, et al.
Published: (2021-09-01)

Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials
by: Rosario Pivonello, et al.
Published: (2020-12-01)

Invasive fungal infections in endogenous Cushing’s syndrome
by: Rafael Selbach Scheffel, et al.
Published: (2010-06-01)

Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study
by: Rosario Pivonello, et al.
Published: (2021-07-01)

Steroid Induced Cushing’s Syndrome in an Asthmatic patient: a Case Report
by: Sumol RATNA, et al.
Published: (2023-09-01)

Evaluation of ketoconazole as a treatment for Cushing’s disease in a retrospective cohort
by: Camila Viecceli, et al.
Published: (2022-10-01)

Corrigendum: Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study
by: Rosario Pivonello, et al.
Published: (2022-04-01)

Case Report: A Challenging Localization of a Pulmonary Ectopic ACTH-Secreting Tumor in a Patient With Severe Cushing’s Syndrome
by: Andreea Liliana Serban, et al.
Published: (2021-07-01)

Prevalence and risk factors associated with systemic hypertension in dogs with spontaneous hyperadrenocorticism
by: Paula García San José, et al.
Published: (2020-09-01)

Prognosis criteria for remission of hypercorticism after transsphenoidal endoscopic adenomectomy in patients with Cushing’s disease
by: N. V. Kuritsyna, et al.
Published: (2019-08-01)

Cushing’s Syndrome – An epidemiological study based on a canine population of 21,281 dogs
by: Gaia Carotenuto, et al.
Published: (2019-02-01)

Long-term efficacy and safety of subcutaneous pasireotide alone or in combination with cabergoline in Cushing’s disease
by: Richard A. Feelders, et al.
Published: (2023-10-01)

Fluconazole for Hypercortisolism in Cushing’s Disease: A Case Report and Literature Review
by: Yiming Zhao, et al.
Published: (2020-12-01)

Delineating endogenous Cushing’s syndrome by GC-MS urinary steroid metabotypingResearch in context
by: Leah T. Braun, et al.
Published: (2024-01-01)

Levoketoconazole in the Treatment of Patients With Cushing’s Syndrome and Diabetes Mellitus: Results From the SONICS Phase 3 Study
by: Rosario Pivonello, et al.
Published: (2021-04-01)

The diagnostic challenge of Cushing’s disease in pediatrics: cases report
by: Medina-Paternina, Olga, et al.
Published: (2022-10-01)

Lipid Abnormalities in Patients With Cushing’s Disease and Its Relationship With Impaired Glucose Metabolism
by: Xiaolin Sun, et al.
Published: (2021-02-01)

A Comprehensive Approach to Predicting the Outcomes of Transsphenoidal Endoscopic Adenomectomy in Patients with Cushing’s Disease
by: Natalia V. Kuritsyna, et al.
Published: (2022-05-01)

Impaired quality of life, but not cognition, is linked to a history of chronic hypercortisolism in patients with Cushing’s disease in remission
by: Emilie Pupier, et al.
Published: (2022-08-01)

Carcinoma adrenal de rápida evolución
by: Teresa Margarita González Calero, et al.

Choroidal thickness and retinal abnormalities by optical coherence tomography in endogenous Cushing’s syndrome
by: Maria Fernanda Abalem, et al.
Published: (2016-12-01)

Cerebrospinal fluid rhinorrhea as a complication of ACTH-secreting pituitary macroadenoma in a patient with morbid obesity
by: Dar'ya Viktorovna Petrova, et al.
Published: (2014-12-01)

HYPERCORTISOLISM: CLASSIFICATION, PATHOGENESIS, CLINICAL MANIFESTATIONS. DIAGNOSIS OF ENDOGENOUS HYPERCORTISOLISM
by: Nikonova L. V., et al.
Published: (2017-02-01)

Clinical Characteristics for the Improvement of Cushing's Syndrome Complicated With Cardiomyopathy After Treatment With a Literature Review
by: Sisi Miao, et al.
Published: (2021-12-01)

Utilization of bilateral percutaneous microwave ablation of the adrenal glands in ectopic Cushing's syndrome
by: Lloyd Petty, MD, et al.
Published: (2022-12-01)

CLINICAL MANIFESTATIONS OF CUSHING'S DISEASE (RESULTS OF ANALYSIS OF THE CLINICAL DATABASE OF THE MOSCOW REGION)
by: I. V. Komerdus, et al.
Published: (2016-12-01)

Is ectopic Cushing’s syndrome underdiagnosed in patients with small cell lung cancer?
by: Marta Piasecka, et al.
Published: (2022-08-01)

Case Report: Consecutive Adrenal Cushing’s Syndrome and Cushing’s Disease in a Patient With Somatic CTNNB1, USP8, and NR3C1 Mutations
by: Mario Detomas, et al.
Published: (2021-08-01)

Biochemical and Radiological Changes in Liver Steatosis Following Mifepristone Treatment in Patients With Hypercortisolism
by: John C. Parker, MD, et al.
Published: (2022-01-01)

Canine endogenous adrenocorticotrophic hormone preanalytical stability after sample shipping in dry ice or recyclable ice bars
by: Álan Gomes Pöppl, et al.
Published: (2020-11-01)

Preventive strategies for hypercoagulation in Cushing’s syndrome: when and how
by: Valentim Lopes, et al.
Published: (2023-07-01)

Dynamics of NT-proBNP and ST2 levels as markers of heart failure in patients with endogenous Cushing syndrome (hypercortisolism)
by: Raisa S. Kosharnaia, et al.
Published: (2023-01-01)

Practical Considerations for the Management of Cushing's Disease and COVID-19: A Case Report
by: Federica Beretta, et al.
Published: (2020-09-01)

Response to Osilodrostat Therapy in Adrenal Cushing’s Syndrome
by: Stasiak M, et al.
Published: (2024-04-01)